2163 related articles for article (PubMed ID: 19403881)
41. Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response.
Shankar LK; Huang E; Litiere S; Hoekstra OS; Schwartz L; Collette S; Boellaard R; Bogaerts J; Seymour L; deVries EGE
Clin Cancer Res; 2023 Jan; 29(1):143-153. PubMed ID: 36302172
[TBL] [Abstract][Full Text] [Related]
42. Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma.
Ferdinandus J; Barbato F; Chodyla M; Fendler WP; Kessler L; Pomykala KL; Metzenmacher M; Krefting F; Hager T; Umutlu L; Herrmann K; Christoph DC
J Nucl Med; 2021 Feb; 62(2):191-194. PubMed ID: 32532926
[TBL] [Abstract][Full Text] [Related]
43. Utility of fluorodeoxyglucose-positron emission tomography in the identification of new lesions in lung cancer patients for the assessment of therapy response.
Obrzut S; Bykowski J; Badran K; Hayeri MR; Hoh CK
Nucl Med Commun; 2010 Dec; 31(12):1008-15. PubMed ID: 20926977
[TBL] [Abstract][Full Text] [Related]
44.
Kirchner J; Hatzoglou V; Buthorn JB; Bossert D; Sigler AM; Reiner AS; Ulaner GA; Diamond EL
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1154-1165. PubMed ID: 33057928
[TBL] [Abstract][Full Text] [Related]
45.
Grueneisen J; Schaarschmidt B; Demircioglu A; Chodyla M; Martin O; Bertram S; Wetter A; Bauer S; Fendler WP; Podleska L; Forsting M; Herrmann K; Umutlu L
J Nucl Med; 2019 Nov; 60(11):1537-1542. PubMed ID: 30926647
[TBL] [Abstract][Full Text] [Related]
46. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
[TBL] [Abstract][Full Text] [Related]
47. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
[TBL] [Abstract][Full Text] [Related]
48. Assessing tumor response to therapy.
Weber WA
J Nucl Med; 2009 May; 50 Suppl 1():1S-10S. PubMed ID: 19380403
[TBL] [Abstract][Full Text] [Related]
49. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
50. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
51. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
52. Quantitative Comparison of Prone and Supine PERCIST Measurements in Breast Cancer.
Whisenant JG; Williams JM; Kang H; Arlinghaus LR; Abramson RG; Abramson VG; Fakhoury K; Chakravarthy AB; Yankeelov TE
Tomography; 2020 Jun; 6(2):170-176. PubMed ID: 32548293
[TBL] [Abstract][Full Text] [Related]
53. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
[TBL] [Abstract][Full Text] [Related]
54. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
[TBL] [Abstract][Full Text] [Related]
55. Early detection of disease progression after palliative chemotherapy in NSCLC patients by (18)F-FDG-PET.
Tauhardt E; Reissig A; Winkens T; Freesmeyer M
Nuklearmedizin; 2014; 53(5):197-204. PubMed ID: 24986272
[TBL] [Abstract][Full Text] [Related]
56. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.
Frings V; van Velden FH; Velasquez LM; Hayes W; van de Ven PM; Hoekstra OS; Boellaard R
Radiology; 2014 Nov; 273(2):539-48. PubMed ID: 24865311
[TBL] [Abstract][Full Text] [Related]
57. Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
Necib H; Garcia C; Wagner A; Vanderlinden B; Emonts P; Hendlisz A; Flamen P; Buvat I
J Nucl Med; 2011 Mar; 52(3):354-61. PubMed ID: 21345787
[TBL] [Abstract][Full Text] [Related]
58. Usefulness of standardized uptake value normalized by individual CT-based lean body mass in application of PET response criteria in solid tumors (PERCIST).
Narita A; Shiomi S; Katayama Y; Yamanaga T; Daisaki H; Hamada K; Watanabe Y
Radiol Phys Technol; 2016 Jul; 9(2):170-7. PubMed ID: 26873140
[TBL] [Abstract][Full Text] [Related]
59. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
[TBL] [Abstract][Full Text] [Related]
60. Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.
O JH; Lodge MA; Wahl RL
Radiology; 2016 Aug; 280(2):576-84. PubMed ID: 26909647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
